Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neuroleptic-induced metabolic syndrome and switch to aripiprazole or ziprasidone
2006-004036-71Phase 4Completed
- Sponsor
- Medical University of Graz
- Start
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of aripiprazole and ziprasidone in schizophrenia, schizoaffective disorder and acute polymorphic psychotic disorder (APPD) (2 arms), sponsored by Medical University of Graz. Started Oct 2006; status: completed.
02
Drugs
aripiprazoleziprasidone
03
Conditions
schizophreniaschizoaffective disorderacute polymorphic psychotic disorder (APPD)
Beyond the preview
Go deeper on 2006-004036-71.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004036-71.